Brian Wiley
2016
In 2016, Brian Wiley earned a total compensation of $1.6M as Chief Commercial Officer at NewLink Genetics, a 14% increase compared to previous year.
Compensation breakdown
| Bonus | $19,525 |
|---|---|
| Non-Equity Incentive Plan | $64,873 |
| Option Awards | $637,668 |
| Salary | $370,700 |
| Stock Awards | $465,208 |
| Other | $22,755 |
| Total | $1,580,729 |
Wiley received $637.7K in option awards, accounting for 40% of the total pay in 2016.
Wiley also received $19.5K in bonus, $64.9K in non-equity incentive plan, $370.7K in salary, $465.2K in stock awards and $22.8K in other compensation.
Rankings
In 2016, Brian Wiley's compensation ranked 6,007th out of 14,075 executives tracked by ExecPay. In other words, Wiley earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,007 out of 14,075 | 57th |
Division Manufacturing | 2,186 out of 5,489 | 60th |
Major group Chemicals And Allied Products | 716 out of 1,895 | 62nd |
Industry group Drugs | 539 out of 1,538 | 65th |
Industry Pharmaceutical Preparations | 422 out of 1,176 | 64th |
Source: SEC filing on March 31, 2017.
Wiley's colleagues
We found five more compensation records of executives who worked with Brian Wiley at NewLink Genetics in 2016.
2016
Charles Link
NewLink Genetics
Chief Executive & Scientific Officer
2016
Nicholas Vahanian
NewLink Genetics
Chief Medical Officer
2016
John Henneman
NewLink Genetics
Chief Financial Officer
2016
Eugene Kennedy
NewLink Genetics
Chief Medical Officer
2016
Carl Langren
NewLink Genetics